文献速递肿瘤 PET/CT

68Ga-DOTATATE PET/CT中肝脏局灶性脂肪 sparing 的假阳性表现

68Ga-DOTATATE PET/CT in Focal Fatty Sparing of the Liver.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本文报道一例69岁女性肺类癌术后患者,随访68Ga-DOTATATE PET/CT发现肝脏局灶性摄取,最初疑为肝转移,但MRI证实为背景弥漫性肝脂肪变中的局灶性脂肪 sparing(良性肝实质),提示该类表现可显著模仿神经内分泌肿瘤肝转移。

要点

  • 68Ga-DOTATATE PET/CT肝脏局灶性摄取需警惕脂肪 sparing 所致假阳性。
  • MRI可用于鉴别局灶性脂肪 sparing 与肝转移。
  • 神经内分泌肿瘤随访中肝局灶性摄取应结合多模态影像确认。

核心结论

  • 肝脏局灶性脂肪 sparing 可在68Ga-DOTATATE PET/CT上表现为局灶性摄取,模仿神经内分泌肿瘤肝转移,属于潜在假阳性发现。

研究设计与样本

  • 本文为个案报道,对象为一名69岁肺类癌术后女性,系列随访行68Ga-DOTATATE PET/CT,并以MRI作为相关性影像验证。

主要发现

  • 系列随访68Ga-DOTATATE PET/CT发现肝脏局灶性摄取,最初被推测为肝转移。
  • MRI相关性影像显示该区域为良性肝实质构成的局灶性脂肪 sparing,背景为弥漫性肝脂肪变。

关键数值与推荐

  • MRI证实局灶性脂肪 sparing 由良性肝实质组成,背景为弥漫性肝脂肪变。

临床怎么用

  • 神经内分泌肿瘤68Ga-DOTATATE PET/CT随访中遇肝脏局灶性摄取时,应结合MRI等影像鉴别脂肪 sparing 与转移。

局限性

  • 本文为单一病例报道,结论的外推性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ga-DOTATATE imaging is commonly used for the detection of metastatic disease in neuroendocrine tumors. We present a case of a 69-year-old woman postsurgery for lung carcinoid tumor in which sequential follow-up Ga-DOTATATE PET/CT studies identified focal hepatic uptake that was presumed to represent a liver metastasis. However, correlative imaging with MRI revealed a focal fatty sparing of the liver composed of benign hepatic parenchyma at that area accompanied with diffuse liver steatosis in the background of the "pseudolesion." This report demonstrates a potential "false-positive" hepatic finding that can strikingly mimic a metastasis in neuroendocrine tumor imaging.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Hod N, Levin D, Anconina R, et al. 68Ga-DOTATATE PET/CT in Focal Fatty Sparing of the Liver. Clin Nucl Med. 2019. PMID: 31348090. doi:10.1097/RLU.0000000000002746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。